Cdk9 phosphorylates p53 on serine 392 independently of CKII

The tumor suppressor p53 is an important cellular protein, which controls cell cycle progression. Phosphorylation is one of the mechanisms by which p53 is regulated. Here we report the interaction of p53 with another key regulator, cdk9, which together with cyclin T1 forms the positive transcription elongation complex, p‐TEFb. This complex cooperates with the HIV‐1 Tat protein to cause the phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase II and this facilitates the elongation of HIV‐1 transcription. We demonstrate that cdk9 phosphorylates p53 on serine 392 through their direct physical interaction. Results from protein–protein interaction assays revealed that cdk9 interacts with the C‐terminal domain (aa 361–393) of p53, while p53 interacts with the N‐terminal domain of cdk9. Transfection and protein binding assays (EMSA and ChIP) demonstrated the ability of p53 to bind and activate the cdk9 promoter. Interestingly, cdk9 phosphorylates serine 392 of p53, which could be also phosphorylated by casein kinase II. Kinase assays demonstrated that cdk9 phosphorylates p53 independently of CKII. These studies demonstrate the existence of a feedback‐loop between p53 and cdk9, pinpointing a novel mechanism by which p53 regulates the basal transcriptional machinery. J. Cell. Physiol. 208: 602–612, 2006. © 2006 Wiley‐Liss, Inc.

[1]  L. Johnson,et al.  Exploiting structural principles to design cyclin-dependent kinase inhibitors. , 2005, Biochimica et biophysica acta.

[2]  M. Shah,et al.  Targeting the cell cycle: a new approach to cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  K. Khalili,et al.  p73 Interacts with Human Immunodeficiency Virus Type 1 Tat in Astrocytic Cells and Prevents Its Acetylation on Lysine 28 , 2005, Molecular and Cellular Biology.

[4]  Hong Yang,et al.  Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis*♦ , 2004, Journal of Biological Chemistry.

[5]  K. Khalili,et al.  Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes* , 2004, Journal of Biological Chemistry.

[6]  Joonhee Kim,et al.  Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability , 2004, FEBS letters.

[7]  X. Graña,et al.  Cellular control of gene expression by T-type cyclin/CDK9 complexes. , 2004, Gene.

[8]  A. Rice,et al.  Human Immunodeficiency Virus Type 1 Infection Induces Cyclin T1 Expression in Macrophages , 2004, Journal of Virology.

[9]  Xin Lu,et al.  Ser392 Phosphorylation Regulates the Oncogenic Function of Mutant p53 , 2004, Cancer Research.

[10]  Patrick Dowd,et al.  The ubiquitin ligase COP1 is a critical negative regulator of p53 , 2004, Nature.

[11]  C. Harris,et al.  p53: 25 years after its discovery. , 2004, Trends in pharmacological sciences.

[12]  Guillermina Lozano,et al.  MDM2, an introduction. , 2003, Molecular cancer research : MCR.

[13]  Takashi Okamoto,et al.  c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis , 2003, Oncogene.

[14]  A. L. Okorokov p53 in a Crosstalk Between DNA Repair and Cell Cycle Checkpoints , 2003, Cell cycle.

[15]  G. Melino,et al.  p53: 25 years of research and more questions to answer , 2003, Cell Death and Differentiation.

[16]  Guillermina Lozano,et al.  Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation , 2003, Cell.

[17]  S. Shuman,et al.  Interactions between Fission Yeast Cdk9, Its Cyclin Partner Pch1, and mRNA Capping Enzyme Pct1 Suggest an Elongation Checkpoint for mRNA Quality Control* , 2003, The Journal of Biological Chemistry.

[18]  M. Oren,et al.  The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.

[19]  A. Giordano,et al.  Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines , 2002, Oncogene.

[20]  A. Giordano,et al.  Interplay between cdk9 and NF-κB factors determines the level of HIV-1 gene transcription in astrocytic cells , 2002, Oncogene.

[21]  A. Giordano,et al.  Physical interaction between pRb and cdk9/cyclinT2 complex , 2002, Oncogene.

[22]  Z. Ronai,et al.  p53-Mdm2--the affair that never ends. , 2002, Carcinogenesis.

[23]  G. Johnson,et al.  Cdk5 phosphorylates p53 and regulates its activity , 2002, Journal of neurochemistry.

[24]  T. Shono,et al.  Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. , 2002, Cancer research.

[25]  D. Meek p53 Induction: Phosphorylation Sites Cooperate in Regulating Interatction , 2002, Cancer biology & therapy.

[26]  P. Farnham,et al.  Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. , 2002, Methods.

[27]  K. Vousden,et al.  Activation and activities of the p53 tumour suppressor protein , 2001, British Journal of Cancer.

[28]  Tamás Kiss,et al.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes , 2001, Nature.

[29]  J. Karn,et al.  Activation of Human Immunodeficiency Virus Transcription in T Cells Revisited: NF-κB p65 Stimulates Transcriptional Elongation , 2001, Journal of Virology.

[30]  A. Giordano,et al.  New insight in cdk9 function: from Tat to MyoD. , 2001, Frontiers in bioscience : a journal and virtual library.

[31]  M. Clarke,et al.  Regulation of p53 localization. , 2001, European journal of biochemistry.

[32]  S. T. Kim,et al.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. , 2001, Genes & development.

[33]  Chawnshang Chang,et al.  Androgen Receptor Interacts with the Positive Elongation Factor P-TEFb and Enhances the Efficiency of Transcriptional Elongation* , 2001, The Journal of Biological Chemistry.

[34]  A. Rice,et al.  Antiapoptotic Function of Cdk9 (TAK/P-TEFb) in U937 Promonocytic Cells , 2001, Journal of Virology.

[35]  M. Kapoor,et al.  A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. , 2001, Molecular cell.

[36]  K. Khalili,et al.  Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* , 2000, The Journal of Biological Chemistry.

[37]  E. Sausville,et al.  Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication* , 2000, The Journal of Biological Chemistry.

[38]  A. Rice,et al.  Genomic organization and characterization of promoter function of the human CDK9 gene. , 2000, Gene.

[39]  Shengyun Fang,et al.  Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.

[40]  A. Giordano,et al.  Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation , 2000, Oncogene.

[41]  Junmin Peng,et al.  Cyclin K Functions as a CDK9 Regulatory Subunit and Participates in RNA Polymerase II Transcription* , 1999, The Journal of Biological Chemistry.

[42]  A. Giordano,et al.  Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo , 1999, Oncogene.

[43]  M. Kapoor,et al.  The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. , 1999, Biochemical and biophysical research communications.

[44]  J. Karn,et al.  Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. , 1999, Journal of molecular biology.

[45]  M. Mathews,et al.  Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate , 1999, Journal of Virology.

[46]  Weiya Ma,et al.  p38 Kinase Mediates UV-induced Phosphorylation of p53 Protein at Serine 389* , 1999, The Journal of Biological Chemistry.

[47]  M. Kubbutat,et al.  Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.

[48]  A. Giordano,et al.  Binding of CDK9 to TRAF2 , 1998, Journal of cellular biochemistry.

[49]  M. Garber,et al.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.

[50]  V. Adler,et al.  Mdm2 association with p53 targets its ubiquitination , 1998, Oncogene.

[51]  K. Khalili,et al.  Cooperative Actions of HIV-1 Vpr and p53 Modulate Viral Gene Transcription* , 1998, The Journal of Biological Chemistry.

[52]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[53]  D. Hazuda,et al.  P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.

[54]  A. Levine,et al.  The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro , 1997, Molecular and cellular biology.

[55]  H. Sakamoto,et al.  Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. , 1997, Biochemistry.

[56]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[57]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[58]  X. Graña,et al.  Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.

[59]  M. Fiscella,et al.  The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. , 1994, Oncogene.

[60]  A. Giordano,et al.  PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Lane,et al.  Regulation of the specific DNA binding function of p53 , 1992, Cell.

[62]  C. Delphin,et al.  Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation. , 1992, The Journal of biological chemistry.

[63]  D. Meek,et al.  The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. , 1990, The EMBO journal.

[64]  B. Gusterson,et al.  Ser 392 Phosphorylation Regulates the Oncogenic Function of Mutant p 53 , 2004 .

[65]  M. Clarke,et al.  Regulation of p 53 localization , 2001 .

[66]  A. Rice,et al.  Antiapoptotic Function of Cdk 9 ( TAK / P-TEFb ) in U 937 Promonocytic Cells , 2000 .